Theravance Inc. (THRX) Reports In-Line Q1 EPS
Tweet
Share
E-mailGet Alerts THRX Hot Sheet
Price: $4.06 --0%
Financial Fact:
Research and development: 286K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Research and development: 286K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Theravance Inc. (NASDAQ: THRX) reported Q1 EPS of ($0.28), in-line with the analyst estimate of ($0.28). Revenue for the quarter came in at $6.3 million versus the consensus estimate of $6.52 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
- Range Impact, Inc. (RNGE) Reports Q2 Loss of $0.02
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
